Experts name 3 ASX 200 giants to sell today

Leading investment experts are calling time on these three outperforming ASX 200 giants. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After a year of solid outperformance, it may be time to hit the sell button on these three S&P/ASX 200 Index (ASX: XJO) giants.

That's according to Family Financial Solutions' Jabin Hallihan and Alto Capital's Tony Locantro, who believe the companies' outperformance over the past months leaves them in overvalued territory (courtesy of The Bull).

The ASX 200 giants facing the analysts' knife are National Australia Bank Ltd (ASX: NAB), which has a market cap of just under $135 billion; Wesfarmers Ltd (ASX: WES), which commands a market cap of $99 billion; and Northern Star Resources Ltd (ASX: NST), with a market cap of just over $40 billion.

Atop of the dividends all three companies pay, NAB shares have gained 8.5% over the past 12 months; Wesfarmers shares are up 14.9%; and Northern Star shares have rocketed 57.8%.

Now, here's why it may be time to take profits.

Time to sell written on a clock.

Image source: Getty Images

ASX 200 giants on the chopping block

"NAB is Australia's largest business bank, benefiting from an oligopolistic market structure," Family Financial Solutions' Hallihan noted.

Commenting on his sell recommendation on this ASX 200 giant, Hallihan said:

Statutory net profit of $6.759 billion in full year 2025 was down 2.9% on the prior corresponding period. A credit impairment charge of $833 million was up from $728 million in the previous year.

In our view, the shares are materially overvalued and leave little margin for error. Capital is better redeployed into discounted quality.

Hallihan also has a sell recommendation on Wesfarmers shares.

"This industrial conglomerate owns high quality businesses, such as Bunnings and Kmart Group," he said.

"The company is diversified, with other businesses including Officeworks, Wesfarmers Chemicals, Energy and Fertilisers and industrial safety," he added. "Diversification is a benefit as it spreads risk."

But Hallihan is also concerned over this ASX 200 giant's current valuation. He concluded:

However, in our view, the stock remains significantly overvalued, with optimism already priced in. The stock was recently trading on a lofty price/earnings ratio above 32 times, so it's exposed to a correction on signs of any weakness.

We would be inclined to trim holdings and re-invest the proceeds in stocks offering better value.

Also tipped as a sell

Alto Capital's Tony Locantro noted, "Northern Star's share price has performed strongly, supported by higher gold prices and improved sentiment towards large market capitalisation producers."

But with the ASX 200 giant running into some recent operational headwinds, Locantro concluded:

However, the company's most recent production report disappointed, with output and cost guidance undershooting market expectations. While the longer-term outlook for gold remains positive, recent operational softness tempers near term confidence.

With much of the upside already reflected in the share price, the risk-reward balance favours taking profits at current levels.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »